provides

Bavarian Nordic Reports Preliminary 2025 Financial Results and Provides Guidance for 2026

Exceeding latest 2025 guidance following a strong performance from both commercial arms of the business in Travel Health and Public…

17 hours ago

Phaos Technology Holdings (Cayman) Limited Provides Response to Unusual Market Action

SINGAPORE, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Phaos Technology Holdings (Cayman) Limited, (NYSE American: POAS), (“the Company”), an advanced microscopy…

1 week ago

New Study Reveals Organic NatureKnit Provides Greater Prebiotic Benefits Than Purified Fibers

MOMENCE, Ill., Jan. 21, 2026 /PRNewswire/ -- New research published in Frontiers in Nutrition has revealed the significant impact of Organic…

3 weeks ago

Valneva Provides Update on Chikungunya Vaccine IXCHIQ

Company voluntarily withdraws IXCHIQ BLA and IND in the U.S. Continuing review of global product opportunity according to medical need and…

3 weeks ago

InspireSemi Provides Administrative Updates

VANCOUVER, British Columbia and AUSTIN, Texas, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Inspire Semiconductor Holdings Inc. (“InspireSemi” or the “Company”)…

4 weeks ago

Inside information: Orion provides outlook for 2026 and estimates that the annual Nubeqa net sales recorded by Orion has potential to exceed EUR 1 billion in the future

January 14, 2026 01:30 ET  | Source: Orion Oyj ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION 14 JANUARY 2026 at…

4 weeks ago

Krystal Biotech Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference

January 11, 2026 13:00 ET  | Source: Krystal Biotech, Inc. Preliminary 4Q 2025 VYJUVEK net revenue of $106 million to…

1 month ago

Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response

• Patient 1 of Cohort 1 has now completed the 24-month follow-up timepoint, and at month-24 post-treatment Patient 1 continued…

1 month ago

Ascendis Pharma Provides Business and Strategic Roadmap Update at 44th Annual J.P. Morgan Healthcare Conference

- Rapidly transforming into a leading global biopharma company January 09, 2026 18:01 ET  | Source: Ascendis Pharma COPENHAGEN, Denmark,…

1 month ago

Greenwich LifeSciences Provides Additional Updates on FLAMINGO-01 and Corporate Strategy

STAFFORD, Texas, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused…

2 months ago